期刊文献+

Crystal Structure of PAI-1 in Complex with Gallate 被引量:1

Crystal Structure of PAI-1 in Complex with Gallate
下载PDF
导出
摘要 PAI-1 is the primary physiologic inhibitor of urokinase-type plasminogen activator (uPA) and tissue-type plasminogen activator (tPA) and plays important roles in a number of physiologic processes including fibrinolysis, angiogenesis, wound healing, and cell migration. PAI-1 has been proposed as a potential target for inhibitor development and many inhibitors have been reported. However, little was known about the inhibitory mechanism of these inhibitors. Here we determine the crystal structure of PAI-1 in complex with a reported inhibitor, sodium gallate. The PAI-1 :gallate structure shows that gallate inserts into the cavity formed by helix D, helix E, helix F and t-strand 2A. This work provides insights into the inhibitory mechanism of gallate and lays out structural basis for further PAI-I inhibitor design. PAI-1 is the primary physiologic inhibitor of urokinase-type plasminogen activator (uPA) and tissue-type plasminogen activator (tPA) and plays important roles in a number of physiologic processes including fibrinolysis, angiogenesis, wound healing, and cell migration. PAI-1 has been proposed as a potential target for inhibitor development and many inhibitors have been reported. However, little was known about the inhibitory mechanism of these inhibitors. Here we determine the crystal structure of PAI-1 in complex with a reported inhibitor, sodium gallate. The PAI-1 :gallate structure shows that gallate inserts into the cavity formed by helix D, helix E, helix F and t-strand 2A. This work provides insights into the inhibitory mechanism of gallate and lays out structural basis for further PAI-I inhibitor design.
出处 《Chinese Journal of Structural Chemistry》 SCIE CAS CSCD 2013年第7期1005-1012,共8页 结构化学(英文)
基金 Supported by the National Natural Science Foundation of China (31161130356, 30770429)
关键词 crystal structure plasmiuogen activator inhibitor PAI-1 inhibitors crystal structure, plasmiuogen activator inhibitor, PAI-1 inhibitors
  • 相关文献

参考文献37

  • 1Andreascn, P. A.; Kjoller, L.; Christensen. L.; Duffy, M. J. The urokinase-lype plasminogen activator system in cancer metastasis: a review. Int. J, Cancer 1997, 72, 1-22. 被引量:1
  • 2Vaughan, D. E. Plasminogen activator inhibitor-l: a common denominator in cardiovascular disease. J. lnvestig. Med 1998, 46, 370-6. 被引量:1
  • 3(Eren, M.; Painter, C. A.; Atkinson, J. B.; Declerck, P. J.; Vaughan, D. E, Age-dependent spontaneous coronary arterial thrombosis in transgenic mice that express a stable form of human plasminogen activator inhibitor-1. Circulotion 2002, 106, 491-6. 被引量:1
  • 4Erickson, L, A.; Fici, G. J.; Lund, J. E.: Boyle, T. P.; Polites, H. G.; Marotti, K. R. Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-I gene. Nature 19911, 346, 74-6. 被引量:1
  • 5Carmeliet, P.; Stassen, J. M.; Schoonjans, L.: Ream, B.; van den Oord, ,J..J.; De Mol, M.: Mulligan, R. C.; Collen, D. Plasminogen activator inhibitor-I gene-deficieot mice. 11. Effects on hemostasis, thrombosis, and thrombolysis. J, Clin. Invest. 1993, 92, 2756-60,. 被引量:1
  • 6Abrahamsson, T.; Nerme, V.; Stromqvist, M.; Akerblom, B.; Legnehed, A.; Pettersson, K.; Westin, E. A. Anti-thrombotic effect of a PAl-1 inhibitor in rats given endotoxin. Thromb. Haemost. 1996, 75, 118-26. 被引量:1
  • 7Van Giezen, J. J.: Wahlund, G.; Abrahamsson, T. The Fab-fragment ofa PAH inhibiting antibody reduces thrombus size and restores blood flow in a rat model of arterial thrombosis, Thromb. Haemost. 1997, 77, 964-9. 被引量:1
  • 8Deng, G.; Curriden, S. A.; Wang, S.; Rosenberg, S.; Loskutoff, D. J. urokinase receptor-mediated cell adhesion and re/ease? J. Cell BioL 1996, Is plasminogen activator inhibitor-I the molecular switch that governs 134, 1563-71. 被引量:1
  • 9Stefansson, S.; Lawrence, D. A. The serpin PAH inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin. Nature 1996 383, 441-3. 被引量:1
  • 10Bajou, K.; Noel, A.: Gerard, R. D.; Masson, V.; Brunner, N.; Holst-Hansen, C.; Skobe, M.; Fusenig, N. E,; Carmeliet, P.; Collen, D. Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularizalion. Nat. Med. 1998, 4, 923-8. 被引量:1

同被引文献2

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部